MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro

por Lisa Svartdal Normann, Miriam Ragle Aure, Suvi-Katri Leivonen, Mads Haugland Haugen, Vesa Hongisto, Vessela N. Kristensen, Gunhild Mari Mælandsmo, Kristine Kleivi Sahlberg
Publicado 2021